Methods to obtain informed consent digitally or electronically may increase the participation of racially and geographically diverse pregnant women in prospective research, which is essential to improve the evidence base for maternity care. We evaluated the feasibility and utility of e-consent in the first year of a multiyear clinical trial involving pregnant women. Of the 86 women screened, 71 were eligible, 65 (93% of eligible) agreed to review the e-consent form, and 61 (86% of eligible) completed the e-consent process. Of the interested women who were sent the e-consent link, all were able to complete the e-consent process, even those who reported low health literacy. Women of all racial and ethnic groups were equally likely to consent, and the sample of women who consented was consistent with practice demographics. E-consent is feasible and easy to use with pregnant women and may expedite enrollment of a representative sample. JOGNN, 47, 529-534; 2018 . https://doi.org/10.1016/j.jogn.2018 Accepted April 2018 T here is an urgent need to engage women in perinatal research to expand the evidence base for clinical care. In the past, legal stipulations designed to protect the woman and fetus stifled prospective research involving pregnant women (Blehar et al., 2013; Welch et al., 2015; White, 2015) . Although restrictions have been relaxed to allow research with pregnant women after informed consent, strong evidence to support much of current maternity care is lacking (American College Obstetricians and Gynecologists, 2015; Foulkes, Grady, Spong, Bates, & Clayton, 2011 Protections, 2003). For rigorous research, representative sampling from the target population is required; however, researchers often struggle to recruit diverse samples (Frew et al., 2014) . To improve perinatal outcomes, women of diverse backgrounds need the opportunity to consent to research participation with minimal burden (American College Obstetricians and Gynecologists, 2015; Every Woman Every Child & United Nations, 2015).
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Women receive maternity care at a wide range of facility types that may see only a few pregnant women per day or week, especially in rural areas. Although the use of community-based maternal care increases access to beneficial services, it can complicate researchers' abilities to enroll a diverse cohort representative of a broad population without extensive staff (Hale et al., 2016) . Women can be difficult to enroll in prospective research during pregnancy if they must meet with research staff in person (Frew et al., 2014) because they are often busy with work obligations and/or the care of young children (American College Obstetricians and Gynecologists, 2015; Rocheleau et al., 2017 Informed decisions for research participation are traditionally documented via handwritten signatures; however, paper-based documentation of informed consent has limitations and may hamper women's opportunities to engage in research during pregnancy. When paper forms are used, recruitment and enrollment of individuals in research require trained staff with access to study documents. Movement of paper forms to and from participants is time-consuming and may impede normal clinic flow. Current copies of study forms must be available when a woman is ready to learn about and consent to the study. In addition, a member of the study staff may need to be available to answer the woman's questions as she reads the documents, which can be difficult in a busy clinic or hospital where space is scarce. After hard copy consent documents are signed, staff must move them to secure storage to be archived and ensure they remain accessible to auditors for years.
The use of electronic documentation of informed consent, also known as digital or e-consent, can improve researchers' abilities to access and enroll participants and aids in auditing (U.S. Food and Drug Administration, 2015). E-consent permits informed consent and study enrollment without the need to meet in person or move a physical document between participants and study staff. The use of e-consent streamlines archiving, improves oversight, and is favored over paper-based documentation by the National Institutes of Health and the U.S. Food and Drug Administration (2015) .
One requirement for e-consent is a secure portal, preferably Web-based, for maximum availability. One such portal, Research Electronic Data Capture (REDCap), is a secure research platform used by more than 2,430 institutions on six continents. REDCap is compliant with protection standards for health care and research (Harris et al., 2009) , and its use allows for secure digital completion of consent forms, including participant signature, using a touch screen or mouse. Signed forms can then be downloaded or printed. With the use of REDCap or a similar portal, study documents can be provided to and obtained from participants and then shared among research staff, auditors, monitors, and sponsors.
Although e-consent may require that a participant have some digital literacy, pregnant women are part of a tech-savvy age demographic. Ninetynine percent of people in the United States between the ages of 18 and 29 and 96% of those between the ages of 30 and 49 are Internet users (Pew Research Center, 2018) . Globally, approximately 67% of adults have some form of Internet access (Pew Research Center, 2016) . Of adults in the United States, 79% have completed financial transactions online, which suggests trust of secure Web sites (Smith & Anderson, 2016) . For individuals who are comfortable with online forms and services, the ability to complete consent documents online at a convenient time and location may promote research engagement.
Although e-consent documentation satisfies regulations and may extend access to perinatal research, there are no reports in which the use of e-consent with pregnant women is detailed (Shelton, 2011) . The purpose of this article is to report on the use of this new method of informed consent. We detail the feasibility and utility of the use of telephone discussion and e-consent documentation of informed consent in the first year of a prospective clinical trial to provide information to assist other researchers.
Methods

Design
We opted for e-consent when designing a multiyear clinical trial of a new format of midwifephysician collaboration for prenatal care of moderate-risk women. During the study design, we planned to recruit women from three nursemidwifery clinics in the greater Nashville area for a period of approximately 3 years. We selected e-consent instead of the usual paper consent because women who received prenatal care at our recruitment sites had characteristics consistent with participants in previous studies that showed successful use of e-consent (Rothwell et al., 2014) . The women frequently used a digital patient portal, were part of an Internet-savvy demographic, and often juggled work and/or child care responsibilities. We also needed an approach to The use of e-consent permits informed consent and study enrollment without the need to meet in person.
Electronic Informed Consent in Research consent that facilitated rapid contact because the clinical trial intervention had to occur soon after participants became eligible.
In order to meet the needs of this population and facilitate access to research, we developed a comprehensive informed consent approach that merged telephone discussion with electronic documentation of informed consent. The Vanderbilt Institutional Review Board approved the consent process and all forms before the start of the study. In this article, we report consent outcomes for the first year (July 27, 2016-July 27, 2017) of this ongoing study to expedite dissemination of this method of consent because we have found it helpful in the efficient enrollment of a representative sample from our target population.
Digital Consent Process
When a woman who received prenatal care at one of three recruitment clinics met the inclusion criteria for the clinical trial, a nurse or midwife described the study. If the woman was interested and gave permission, the nurse or midwife sent a message within the electronic medical record portal to the investigator, who called the woman to explain the study, screen for eligibility, and discuss risks and benefits of participation (Phillippi et al., 2016) . After the telephone discussion, a link to the e-consent form was e-mailed via REDCap to eligible, interested women. The link opened a secure Web page that contained the e-consent document, an online version of a standard consent form. The form was visible and functional on Web-enabled computers, tablets, and smartphones, and all response transmissions were encrypted for security. Hard copy informed consent forms were available and could be mailed to a potential participant if she desired.
After the link to the e-consent form was e-mailed, the investigator offered to remain on the phone to answer questions while the woman completed the consent process within REDCap. Alternately, the woman could complete the consent later if she did not want or was not able to complete the process at that time. For example, a woman could read and complete the e-consent while her child napped. If, after reading the study details, the woman wanted to participate, she added her name and age in text boxes and signed the consent form using a mouse or her finger. After completion, she could download or print the signed document. If a woman was sent the link and did not complete the consent, the principal investigator contacted her by phone to see if the e-consent form was a problem and offer an alternative consent process.
If a woman did not want to participate in the clinical trial, the principal investigator had institutional review board approval to note within REDCap the woman's race and ethnicity as stated within her medical record. If a woman consented to participate in the clinical trial, the online platform immediately asked her to complete a demographic questionnaire, including questions about her race and ethnicity, health literacy, socioeconomic status, and social support. We used the 3-question brief health literacy survey validated by Chew et al. (2008) to provide context on the woman's ability to read and comprehend medical information. Information about race and ethnicity was compared against practice-level race/ethnicity data to Telephone contact and digital documentation of informed consent are feasible methods to obtain a representative sample of pregnant women.
determine if any groups of women were less likely to consent electronically than other groups.
Results
Of the 86 women screened for study participation, 71 were eligible, 65 (93% of eligible) agreed to review the e-consent document, and 61 (86% of eligible) consented electronically (see Figure 1 and Table 1 ). Demographic characteristics of eligible women, grouped to show separately those who declined and those who consented, are displayed in Table 1 . Our sample of participants who consented was consistent with the racial/ethnic distribution of women who received prenatal care at this practice (Phillippi et al., 2016) . Of the eligible women, all racial/ ethnic groups were equally likely to consent to participation after screening. All women who entered the study were able to complete the e-consent process (N ¼ 61, 100%). Of women sent the e-consent link, only one had difficulty with the online system and reported signature problems that were ultimately resolved. Even the 5% of participants who reported that they were only somewhat confident in filling out medical forms and the 10% who reported that they experienced problems learning because of difficulty understanding written material some or most of the time on the demographic form were able to complete the online consent document. No one requested a hard copy form or alternative consent process.
Discussion
Results from the first year of our trial show that telephone contact and digital documentation of informed consent are feasible methods to generate a representative sample from a target population of pregnant women. We successfully recruited women from three clinic sites without on-site research staff. Although this shows feasibility at our site, further research is needed at other locations and with other populations. Characteristic Declined (n ¼ 10)
Number with data 9 (90) 61 ( E-consent has the potential to extend the reach of prospective research involving pregnant women from diverse backgrounds to increase the generalizability of results.
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spaces. Greater use of e-consent techniques could expedite enrollment of women from previously hard-to-reach sites such as rural areas or clinics with a low volume of maternity care, allowing more nurses and providers to offer research options to the women they serve.
Equitable access to research participation and the use of informed consent strategies that meet women's needs are consistent with principles of ethical research (National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978) and may be one means to study and address health disparities related to race and geographic location (Blehar et al., 2013; MacDorman, Declercq, Cabral, & Morton, 2016) . Equitable enrollment of women from diverse backgrounds across wider geographic locations improves research rigor and increases the likelihood that findings are generalizable (Blehar et al., 2013) . The use of e-consent has the potential to extend the reach of prospective research involving pregnant women.
E-consent may also assist individuals with low literacy because the electronic document can be programmed to include optional informational videos or have definitions appear when the mouse hovers over a medical term (Allison, 2017) . E-consent can also permit a display of different videos based on the race, ethnicity, culture, or educational level of the participant, and customization of information can facilitate understanding and trust, essential components of research participation (Allison, 2017) .
Although our work demonstrates feasibility and acceptability, rigorous testing could be done to determine if e-consent processes are significantly better than paper-based consent processes for the recruitment of diverse populations and the expansion of recruitment in rural or low-volume health care environments. One such trial, known as Strengthening Translational Research In Diverse Enrollment (STRIDE), is underway at 3 major U.S. research institutions, and researchers will systematically assess differences in equitable recruitment of racial and ethnic minorities between research studies that use e-consent processes and those that use traditional consent methods (Allison, 2017) . Until the completion of this trial, we recommend that perinatal researchers use consent methods that resonate with the target population.
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